Therigy Positions Itself for Growth

The Company Announces Investments in Technology Sales, Marketing, and Client Service Functions Orlando, FL (August 24, 2015) Therigy, LLC, the trusted source for specialty solutions, announced significant investments and organizational changes to better align the company to opportunities for its …

TherigySTM RSV Module Available for RSV Season

TherigySTM RSV clinical module provides superior management and reporting capabilities for specialty pharmacies Cold and flu season is approaching and physicians, parents, and pharmacists know that another RSV season is on the way. RSV, Respiratory Syncytial Virus, is a common …

Understanding URAC 3.0

URAC has recently released Specialty Pharmacy Standards (3.0), and many specialty pharmacies may be uncertain of what these changes will require or how these requirements may affect them upon reaccreditation. “This is not a small update to the standards,” said …

Biosimilars: Financial Predictions of an Emerging Market

The first biosimilar drug recently received FDA approval, and the introduction of this class of specialty pharmaceuticals into the U.S. market will affect prices at all points along the pipeline, from development to end use. “Biosimilars are going to insert …